Healthcare provider profile · identity verified

Ruby M Tucker, M.D.

Internal Medicine · VIRGINIA BEACH, VA · NPI 1194925545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	548	183
Losartan Potassium	Losartan Potassium	432	142
Amlodipine Besylate	Amlodipine Besylate	395	132
Rosuvastatin Calcium	Rosuvastatin Calcium	337	118
Lisinopril	Lisinopril	223	74
Carvedilol	Carvedilol	216	69
Alendronate Sodium	Alendronate Sodium	214	81
Albuterol Sulfate Hfa	Albuterol Sulfate	200	99
Levothyroxine Sodium	Levothyroxine Sodium	193	62
Hydrochlorothiazide	Hydrochlorothiazide	188	64
Pantoprazole Sodium	Pantoprazole Sodium	187	68
Duloxetine Hcl	Duloxetine Hcl	167	54
Fluticasone Propionate	Fluticasone Propionate	163	87
Furosemide	Furosemide	160	66
Trazodone Hcl	Trazodone Hcl	159	57
Montelukast Sodium	Montelukast Sodium	145	54
Ezetimibe	Ezetimibe	139	50
Omeprazole	Omeprazole	137	55
Metformin Hcl	Metformin Hcl	136	46
Hydralazine Hcl	Hydralazine Hcl	130	46
Prednisone	Prednisone	129	83
Metformin Hcl Er	Metformin Hcl	121	44
Quetiapine Fumarate	Quetiapine Fumarate	116	31
Metoprolol Tartrate	Metoprolol Tartrate	115	43
Baclofen	Baclofen	110	52
Sertraline Hcl	Sertraline Hcl	110	39
Eliquis	Apixaban	108	31
Allopurinol	Allopurinol	106	39
Glipizide	Glipizide	101	41
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	99	42
Tamsulosin Hcl	Tamsulosin Hcl	95	34
Potassium Chloride	Potassium Chloride	91	36
Metoprolol Succinate	Metoprolol Succinate	90	29
Famotidine	Famotidine	74	27
Doxycycline Monohydrate	Doxycycline Monohydrate	73	57
Levofloxacin	Levofloxacin	73	53
Mirtazapine	Mirtazapine	69	35
Ibuprofen	Ibuprofen	65	30
Ozempic	Semaglutide	65	15
Oxybutynin Chloride Er	Oxybutynin Chloride	60	24
Gabapentin	Gabapentin	59	29
Fluoxetine Hcl	Fluoxetine Hcl	53	17
Jardiance	Empagliflozin	53	18
Diclofenac Sodium	Diclofenac Sodium	51	33
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	38
Donepezil Hcl	Donepezil Hcl	48	17
Clopidogrel	Clopidogrel Bisulfate	46	24
Triamcinolone Acetonide	Triamcinolone Acetonide	45	26
Bumetanide	Bumetanide	44	21
Ondansetron Odt	Ondansetron	44	26
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	13
Rybelsus	Semaglutide	41	12
Tizanidine Hcl	Tizanidine Hcl	41	21
Finasteride	Finasteride	40	17
Meclizine Hcl	Meclizine Hcl	40	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Azithromycin	Azithromycin	38	29
Warfarin Sodium	Warfarin Sodium	38	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	11
Gemfibrozil	Gemfibrozil	35	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	15
Naproxen	Naproxen	31	16
Hydroxyzine Hcl	Hydroxyzine Hcl	30	13
Cephalexin	Cephalexin	28	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	15
Paxlovid	Nirmatrelvir/Ritonavir	28	27
Bupropion Hcl Sr	Bupropion Hcl	27	13
Methylprednisolone	Methylprednisolone	27	22
Levetiracetam	Levetiracetam	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	14
Simvastatin	Simvastatin	26	11
Synthroid	Levothyroxine Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Lidocaine	Lidocaine	25	13
Nystatin	Nystatin	25	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	24	18
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	14
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Clonidine	Clonidine	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Linzess	Linaclotide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Xarelto	Rivaroxaban	19	suppressed
Topiramate	Topiramate	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	14
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Diazepam	Diazepam	16	suppressed
Amoxicillin	Amoxicillin	15	13
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Fluconazole	Fluconazole	15	13
Clonidine Hcl	Clonidine Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Colchicine	Colchicine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error